Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
68 employees · est. 2019 · Boston, United States
Veocor Diagnostics
Image-based Personalized Diagnostics of Cardiac Clot Risk and Stroke Risk
0-1 employees · San Diego, United States
Pyxis Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Pyxis Oncology | Veocor Diagnostics |
|---|---|---|
| Founded | ||
| Founded | 2019 | Not tracked yet |
| Headquarters | ||
| Headquarters | Boston, United States | San Diego, United States |
| Employees | ||
| Employees | 68 larger | 0-1 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Health Care, Information Technology |
| Funding Stage | ||
| Funding Stage | Unknown | Not tracked yet |
| Total Funding | ||
| Total Funding | $392.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | Not tracked yet |
| Services | ||
| Services | development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development | Not tracked yet |
| Target Customers | ||
| Target Customers | patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibody-Drug Conjugates, Immunotherapy, Cancer Treatment, Biologics, Tumor Targeting, Immune Suppression Overcoming, Tumor Antigen-Specific TILs, Tumor-Infiltrating Lymphocytes, Cold Tumors, Hot Tumors, Tumor Cell Signaling, Antibody-Based Immunotherapies, Oncology Innovation, Therapeutic Development | Cloud-based AI Technologies, Personalized Diagnostics, Cardiac Clot Risk, Stroke Risk, Anticoagulation, Ultrasound Imaging Analysis, Blood Flow Assessment, Thrombus Formation, Quantitative Measure, Left Ventricle Analysis, Medical Imaging, Diagnostic Tools, Cardiovascular Health, Stroke Prevention |
| Website | ||
| Website | pyxisoncology.com | veocordx.com |
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...
About Veocor Diagnostics
Veocor is a healthcare startup based in the United States that focuses on personalized diagnostics for cardiac clot risk and stroke risk. The company's slogan, "Image-based Personalized Diagnostics of Cardiac Clot Risk and Stroke Risk," encapsulates its mission to pioneer cloud-based AI technologies...
We will tell you when either one moves
BounceWatch watches Pyxis Oncology and Veocor Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Pyxis Oncology and Veocor Diagnostics — by email.
Frequently Asked Questions
Compare Pyxis Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Pyxis Oncology on 9 Jun 2026, and Veocor Diagnostics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.